We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$1.51B
AUM Growth
-$77.3M
Cap. Flow
+$91M
Cap. Flow %
6.03%
Top 10 Hldgs %
47.01%
Holding
89
New
28
Increased
20
Reduced
17
Closed
23

Top Buys

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$43.2M
2
BIIB icon
Biogen
BIIB
+$27.9M
3
ORLY icon
O'Reilly Automotive
ORLY
+$26.2M
4
VFC icon
VF Corp
VFC
+$24.3M
5
CMG icon
Chipotle Mexican Grill
CMG
+$23.9M

Top Sells

Rank Stock Value
1
DFRG
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
+$48.8M
2
EPC icon
Edgewell Personal Care
EPC
+$46M
3
BURL icon
Burlington
BURL
+$38.1M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.1M
5
RH icon
RH
RH
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.07%
2 Miscellaneous 28.56%
3 Consumer Discretionary 17.83%
4 Consumer Staples 5.02%
5 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$237M 15.73%
8,000
-1,342,000
-99% -$397M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.4B
$90.8M 6.02%
+6,000
New +$916K
AVTX icon
3
Avalo Therapeutics
AVTX
$1.07B
$68M 4.51%
7,182
+783
+12% +$8.74M
CELG
4
DELISTED
Celgene Corp
CELG
$50.8M 3.37%
512,000
+112,000
+28% +$10.6M
EPC icon
5
CALL
Edgewell Personal Care
EPC
$1.29B
$48.7M 3.23%
+15,000
New +$448K
VNDA icon
6
Vanda Pharmaceuticals
VNDA
$328M
$47.1M 3.12%
3,548,000
+390,000
+12% +$5.44M
AMAG
7
DELISTED
AMAG Pharmaceuticals
AMAG
$46.9M 3.11%
4,060,000
+260,000
+7% +$2.74M
KHC icon
8
Kraft Heinz
KHC
$29.5B
$41.9M 2.78%
+1,500,000
New +$43.2M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$83.6B
$41.1M 2.72%
148,000
+24,000
+19% +$7.1M
HAIN icon
10
CALL
Hain Celestial
HAIN
$61.7M
$36.5M 2.42%
17,000
-1,983,000
-99% -$41.5M
WBT
11
DELISTED
Welbilt, Inc.
WBT
$35.3M 2.34%
2,092,000
-100,000
-5% -$1.62M
ENR icon
12
Energizer
ENR
$1.45B
$34.9M 2.31%
800,000
-548,000
-41% -$21.8M
ENTA icon
13
Enanta Pharmaceuticals
ENTA
$395M
$34.8M 2.31%
580,000
+200,000
+53% +$14.9M
BIIB icon
14
Biogen
BIIB
$31.6B
$34.5M 2.28%
148,000
+120,000
+429% +$27.9M
INCY icon
15
Incyte
INCY
$25.5B
$31.8M 2.11%
428,000
+200,000
+88% +$16.2M
ORLY icon
16
O'Reilly Automotive
ORLY
$69.6B
$26.9M 1.78%
+1,012,500
New +$26.2M
FL
17
DELISTED
Foot Locker
FL
$26.5M 1.76%
615,000
+465,000
+310% +$18.7M
DPLO
18
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$26.5M 1.75%
5,400,000
+2,200,000
+69% +$12.3M
LULU icon
19
lululemon athletica
LULU
$11.3B
$26M 1.72%
135,000
+81,000
+150% +$15.1M
TGT icon
20
Target
TGT
$73.8B
$25.7M 1.7%
240,000
+147,000
+158% +$14M
VFC icon
21
VF Corp
VFC
$5.2B
$25.4M 1.68%
+285,000
New +$24.3M
CMG icon
22
Chipotle Mexican Grill
CMG
$47B
$25.2M 1.67%
+1,500,000
New +$23.9M
ASMB icon
23
Assembly Biosciences
ASMB
$719M
$24.3M 1.61%
205,667
+39,000
+23% +$5.9M
ONCE
24
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$24.2M 1.61%
250,000
+182,000
+268% +$18.2M
BHVN
25
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$24.1M 1.6%
578,000
+418,000
+261% +$17.7M
1
2 3 4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Armistice Capital held 89 positions worth $1.51B, down 4.9% from $1.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Armistice Capital deployed $91M of net new capital in Q3 2019, opening 28 new positions and adding to 20 existing holdings. Its largest new stake was Kraft Heinz: 1,500,000 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 37% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $28.1M trimmed.

  • Armistice Capital's largest Q3 2019 buy was Kraft Heinz: 1,500,000 shares worth $41.9M.
  • Armistice Capital added most to Biogen in Q3 2019, an estimated $27.9M increase.
  • Armistice Capital's biggest Q3 2019 reduction was Madrigal Pharmaceuticals, cutting an estimated $28.1M.
  • Armistice Capital fully exited Del Frisco's Restaurant Group, Inc. Common Stock in Q3 2019, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 47% of its $1.51B portfolio in Q3 2019.
  • Armistice Capital opened 28 new positions and closed 23 in Q3 2019.
  • Armistice Capital's portfolio value fell 4.9% quarter-over-quarter to $1.51B.

Based on Armistice Capital's 13F filing for Q3 2019, filed 14 Nov 2019.